Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Phase I Study of Clofarabine with Standard-Dose Infusional Cytarabine (Ara-C) as Intensive Induction Therapy for Newly-Diagnosed De Novo Acute Myeloid Leukemia in Older Adults Age ≥60 Years.

James Foran, MD, Angelina The, MD, Pam Dixon, RN, Marcel Devetten, MD, Mikkael Sekeres, MD

Blood (2007) 110 (11): 1831.

https://doi.org/10.1182/blood.V110.11.1831.1831

Published: 2007

Journal Articles

c-Kit (CD117) Expression Is a Poor Prognostic Factor for Relapse and Overall Survival in Patients with Newly Diagnosed AML.

Cristina Rodriguez, MD, Tao Jin, MS, Rony Abou Jawde, MD, Wael Saber, MD, Rachid Baz, MD, Eric His, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Mikkael Sekeres, MD, Anjali Advani, MD

Blood (2006) 108 (11): 4510.

https://doi.org/10.1182/blood.V108.11.4510.4510

Published: 2006

Journal Articles

Time to Post-Remission Therapy (PRT) Is an Independent Prognostic Factor for Relapse and Overall Survival in Adults with Acute Lymphocytic Leukemia (ALL).

Anjali Advani, MD, Tao Jin, MS, Ramon Tiu, MD, Giridharan Ramsingh, MD, Christopher Lowe, PharmD, Wael Saber, MD, Ronald Sobecks, MD, Mikkael Sekeres, MD, Shawnda Sungren, BBA, Matt Kalaycio, MD

Blood (2006) 108 (11): 1883.

https://doi.org/10.1182/blood.V108.11.1883.1883

Published: 2006

Journal Articles

Blasts Express Phospho-Akt in the Majority of Adult Patients with Acute Lymphocytic Leukemia (ALL).

Anjali S. Advani, MD, Sarah Gibson, MD, Tao Jin, MS, Ramon Tiu, MD, Giridharan Ramsingh, MD, Matt Kalaycio, MD, Brian Bolwell, MD, Ronald Sobecks, MD, Mikkael Sekeres, MD, Shawnda Sungren, BBA, Eric D. Hsi, MD

Blood (2006) 108 (11): 1846.

https://doi.org/10.1182/blood.V108.11.1846.1846

Published: 2006

Journal Articles

A Quality of Life Assessment of Ablative Allogeneic Bone Marrow Transplant (BMT) Recipients One and Twelve Months after Transplant.

Brian Bolwell, MD, Linda McLellan, LISW, Larry Foster, Ph.D, Lisa Rybicki, Ronald M. Sobecks, MD, Brad Pohlman, MD, Steve Andresen, DO, Elizabeth Kuczkowski, Mary Serafin, R.N., Karen Sands, R.N., Jennifer Kosar, R.N., Stacey Brown, Jennifer Bates, Mikkael Sekeres, MD, MS, Jane Dabney, LISW, Erin Welsh, LSW, Matt Kalaycio, MD

Blood (2005) 106 (11): 1322.

https://doi.org/10.1182/blood.V106.11.1322.1322

Published: 2005

Journal Articles

Cytogenetic Classification Systems and Overall Survival Following Bone Marrow Transplant (BMT) for Acute Myelogenous Leukemia (AML).

Matt Kalaycio, MD, Mikkael Sekeres, MD, Ronald Sobecks, MD, Lisa Rybicki, Brad Pohlman, MD, Anjali Advani, MD, Elizabeth Kuczkowski, Brian Bolwell, MD

Blood (2005) 106 (11): 4500.

https://doi.org/10.1182/blood.V106.11.4500.4500

Published: 2005

Journal Articles

Increased Frequency of Polymorphisms in XRCC3 and OGG1 Genes in Patients with MDS.

Hadrian Szpurka, MSc, Abdo Haddad, MD, Soumit Basu, MD, PhD, Mikkael Sekeres, MD, MSc, Jaroslaw P. Maciejewski, MD, PhD

Blood (2005) 106 (11): 3445.

https://doi.org/10.1182/blood.V106.11.3445.3445

Published: 2005

Journal Articles

CD117 Expression Is a Poor Prognostic Factor (PF) for Progression Free Survival (PFS) and Freedom from Progression (FFP) in Patients with Newly Diagnosed Acute Myelogenous Leukemia (AML).

Wael Saber, MD, Rony Abou-Jawde, MD, Eric Hsi, MD, Tao Jin, MS, Matt Kalaycio, MD, Ronald Sobecks, MD, Mikkael Sekeres, MD, Brad Pohlman, MD, Barbara L. Tripp, RN, Anjali Advani, MD

Blood (2005) 106 (11): 3292.

https://doi.org/10.1182/blood.V106.11.3292.3292

Published: 2005

Journal Articles

A Pilot Application of SELDI-TOF Mass Spectrometry in Bone Marrow Failure Syndromes.

Sujith Rao Kalmadi, MD, Ron Wu, PhD, Zach Nearman, PhD, Paul Elson, PhD, Mikkael Sekeres, MD, MS, Jaroslaw P. Maciejewski, MD, PhD

Blood (2005) 106 (11): 3421.

https://doi.org/10.1182/blood.V106.11.3421.3421

Published: 2005

Journal Articles

Epsilon Aminocaproic Acid (EACA) Reduces Transfusion Requirements in Patients with Thrombocytopenic Hemorrhage.

Sujith Rao Kalmadi, MD, Ramon Tiu, MD, Christopher Lowe, PharmD, Ronald Sobecks, MD, Brian Bolwell, MD, Alan Lichtin, MD, Mohammad Hussein, MD, Jarek Maciejewski, MD, Anjali Advani, MD, Mikkael Sekeres, MD, Steven Andresen, DO, Pohlman Brad, MD, Paul Elson, ScD, Matt Kalaycio, MD

Blood (2004) 104 (11): 3938.

https://doi.org/10.1182/blood.V104.11.3938.3938

Published: 2004

Journal Articles

The Relationship between Weekend Admissions and Outcome in Older Adults with Acute Myelogenous Leukemia (AML).

Ahmed Al-Hazzouri, MD, Lisa Rybicki, Matt Kalaycio, MD, Stacey Brown, Hyo Sook Han, MD, Brad Pohlman, MD, Anjali Advani, MD, Barbara Tripp, Ronald Sobecks, MD, Mikkael Sekeres, MD

Blood (2004) 104 (11): 3140.

https://doi.org/10.1182/blood.V104.11.3140.3140

Published: 2004

Journal Articles

Time to Nadir Peripheral White Blood Cell Count (WBC) and Absolute WBC Nadir Value Following Induction Chemotherapy in Older Adults with Acute Myeloid Leukemia (AML) Predicts Survival.

Hyo Sook Han, MD, Lisa Rybicki, Matt Kalaycio, MD, Stacey Brown, Anjali Advani, MD, Brad Pohlman, MD, Ronald Sobecks, MD, Mikkael Sekeres, MD

Blood (2004) 104 (11): 1074.

https://doi.org/10.1182/blood.V104.11.1074.1074

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Phase I Study of Clofarabine with Standard-Dose Infusional Cytarabine (Ara-C) as Intensive Induction Therapy for Newly-Diagnosed De Novo Acute Myeloid Leukemia in Older Adults Age ≥60 Years.

c-Kit (CD117) Expression Is a Poor Prognostic Factor for Relapse and Overall Survival in Patients with Newly Diagnosed AML.

Time to Post-Remission Therapy (PRT) Is an Independent Prognostic Factor for Relapse and Overall Survival in Adults with Acute Lymphocytic Leukemia (ALL).

Blasts Express Phospho-Akt in the Majority of Adult Patients with Acute Lymphocytic Leukemia (ALL).

A Quality of Life Assessment of Ablative Allogeneic Bone Marrow Transplant (BMT) Recipients One and Twelve Months after Transplant.

Cytogenetic Classification Systems and Overall Survival Following Bone Marrow Transplant (BMT) for Acute Myelogenous Leukemia (AML).

Increased Frequency of Polymorphisms in XRCC3 and OGG1 Genes in Patients with MDS.

CD117 Expression Is a Poor Prognostic Factor (PF) for Progression Free Survival (PFS) and Freedom from Progression (FFP) in Patients with Newly Diagnosed Acute Myelogenous Leukemia (AML).

A Pilot Application of SELDI-TOF Mass Spectrometry in Bone Marrow Failure Syndromes.

Epsilon Aminocaproic Acid (EACA) Reduces Transfusion Requirements in Patients with Thrombocytopenic Hemorrhage.

The Relationship between Weekend Admissions and Outcome in Older Adults with Acute Myelogenous Leukemia (AML).

Time to Nadir Peripheral White Blood Cell Count (WBC) and Absolute WBC Nadir Value Following Induction Chemotherapy in Older Adults with Acute Myeloid Leukemia (AML) Predicts Survival.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only